Overview: Luxturna by Spark Therapeutics
Slides in the pack:
- Gene therapies and LUXTURNA
- Current status of LUXTURNA
- Development timeline: LUXTURNA
- Epidemiology and market opportunity for LUXTURNA
- Steps involved in manufacturing LUXTURNA
- Phase III trial protocol with LUXTURNA
- Safety with LUXTURNA
- Spark Therapeutics: clinical development pipeline
- Replacement gene therapies in development